EP2429558A1 - Medicine for dental diseases prophylaxis - Google Patents

Medicine for dental diseases prophylaxis

Info

Publication number
EP2429558A1
EP2429558A1 EP10775155A EP10775155A EP2429558A1 EP 2429558 A1 EP2429558 A1 EP 2429558A1 EP 10775155 A EP10775155 A EP 10775155A EP 10775155 A EP10775155 A EP 10775155A EP 2429558 A1 EP2429558 A1 EP 2429558A1
Authority
EP
European Patent Office
Prior art keywords
weight
medicine according
magnesium
selected out
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10775155A
Other languages
German (de)
French (fr)
Other versions
EP2429558A4 (en
Inventor
Tamaz Omarovich Manasherov
Svetlana Konstantinovna Matelo
Tat'yana Vladimirovna Kupets
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Obshchestvo S Ogranichennoj Otvetstvennost'yu "WDS"
Original Assignee
Obshchestvo S Ogranichennoj Otvetstvennost'yu "WDS"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obshchestvo S Ogranichennoj Otvetstvennost'yu "WDS" filed Critical Obshchestvo S Ogranichennoj Otvetstvennost'yu "WDS"
Publication of EP2429558A1 publication Critical patent/EP2429558A1/en
Publication of EP2429558A4 publication Critical patent/EP2429558A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • A61K36/03Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9711Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9761Cupressaceae [Cypress family], e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9767Pinaceae [Pine family], e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • the invention relates to therapeutic and prophylactic formulations for oral care utilized in stomatology, particularly to medicine for dental diseases prophylaxis wherein biologically active agents of natural origin are used.
  • tooth paste sold under "Parodontax” brand. It consists of baking soda and a blend of natural ingredients, flavor, sodium fluoride. As natural ingredients it contains a blend of alcohol extracts and oils of echinacea, myrrh, chamomile, rhatany, sage (US 2002/0031481 Al, IPC 7 A61K 7/16, 2002).
  • the known formulation has considerable concentration of baking soda as abrasive, more than 40% by weight that creates hypertonic medium and may result in gingival sponginess and recession. Therefore this tooth paste cannot be viewed as a means for permanent everyday dental and gingival prophylactic care. Moreover the known formulation does not provide necessary hard teeth tissues mineralization.
  • Technical result of the invention is achieved by practical use of effective formulation containing accessible components based on biologically active agents of natural origin, which has a comprehensive effect on dental tissues and can be recommended for periodontium prophylaxis and treatment as well as caries and non-carious affections prophylaxis.
  • the main purpose of this invention was to elaborate high-efficiency formulation for prophylaxis of dental diseases of teeth and soft tissues of oral cavity in which synergist medications could heighten effect of each other attaining high therapeutic effect and results mentioned above.
  • Technical result is enhanced by medicine for dental diseases prophylaxis containing orally acceptable active and inert components.
  • Active components about 0.3% to 2.2% by weight of lipid concentrate of kelp, 0.5% to 5.0 % by weight of kelp salt, 0.5% to 4.0 % by weight of dry extract of liquorice root, 0.01% to 0.25 % by weight of one or more essential oils to enhance organoleptic properties, and 0.1% to 3.5 % by weight of anticaries mineral adjunct. Inert components content is up to 100% by weight.
  • the medicine contains about 0.5% to 1.8% by weight of lipid concentrate of kelp, 0.8% to 4.2 % by weight of kelp salt, 0.8% to 3.6 % by weight of dry extract of liquorice root, 0.03% to 0.22 % by weight of one or more essential oils.
  • essential oils used to improve organoleptic properties
  • essential oils chosen out of the group including anise, thyme, lemon, mandarin, grapefruit, orange, bergamot, nerol, sage, tea tree, manuka, eucalyptus, fir, pine, juniper.
  • Literal sources indicate to great value of biologically active agents contained in various species of kelp. There is shown particular perspective to extract lipid fractions out of laminaria of northern and far eastern seas. (Study and use of therapeutic and prophylactic medicine based on natural biologically active agents / edited by V.G. Bespalov and V.B. Nekrasova. - Spb.: Eskulap, 2000. - pp.175-176).
  • Lipid fractions are extracted in the following way regardless of seaweed species specificity: biologically active agents are ethanol extracted or highly volatile diluent extracted out of dry seaweed, then lipid concentrate and aqueous extract are skimmed.
  • Essential biologically active components of lipid concentrate chlorophyll derivatives, carotinoids (beta-carotine), mannitol, polysaccharides, fatty acids, including essential acids (polyunsaturated acids Cl 8 and C20 omega-3 and omega-6 are most prevalent fatty acids), organically associated phosphor and iodine, sulphur amino acids.
  • seaweed accumulates actively many elements and concentrates various macro-and microelements. While kelp processing there are derived inorganic salts. Biological properties of these compounds are determined by such elements as calcium, iodine, potassium, magnesium, manganese, molybdenium, copper, cobalt, ferrum, germanium, selenium, zink, etc.
  • prophylaxis intensify metabolic processes, improve trophism and blood circulation in periodontal tissues that reduces alveolar bones atrophy, contributes to nonspecific resistance increase.
  • Liquorice root extract has been used for thousands of years as a medicine. Medical opportunities are determined by chemical formulation. Liquorice root contains about 6% to 23% of triterpene saponoside glycyrrhizin, blended potassium-calcium-magnesium salt of glycyrrhizinic acid, derivatives of glycyrrhizinic acid, such as glabric acid, 18-glycyrrhetic, 18,19 - dihydroglycyrrhetic, 11-deoxyglycyrrhetic acids, liquiritic acid; up to 4% of flavonoids: liquiritin, isoliquiritin, licurazid, neoliquiritin, glabroside, uraloside, liquiritoside, glabrol, quercetin, kaempferol, apigenin,; mono- and disaccharides (up to 20%); starch (up to 34%); pectins
  • flavonoids are also active in relation to clarithromycins and amoxycillins resistant strains of Helicobacter pylori (Fukai T., Marumo A., Kaitou K., et al. Anti- Helicobacter pylori flavonoids from licorice extract. Life Sci. 2002 Aug 9;71(12):1449-63.).
  • flavonoids derived from liquorice demonstrated antimicrobial activity against methycillin resistant strains of Staphylococcus aureus with minimum inhibitory concentrations of 3.13 to 12.5 ⁇ g/ml.
  • Flavonois glabren, isolicoflavon, isolicoflavonol showed activity in relation to these strains in concentration of 1.56 to 25.0 ⁇ g/1.
  • Liquorice root extract is used not only in the form of medicine but also for preparing halva and licorice sweets in food industry which makes it attractive as a means for oral hygiene.
  • Lipid concentrate of kelp has offending scent that is negatively commented by some consumers.
  • it has been proposed to introduce one or several ether oils into tooth pastes formulation in order to mask offending scent.
  • ether oils anise, thyme, lemon, mandarin, grapefruit, bergamot, nerol, sage, tea tree, manuka, eucalyptus, fir, pine, juniper.
  • Liquorice extract also has a positive effect on tooth paste flavor.
  • Ether oils coupled with liquorice extract perform a number of antimicrobial functions.
  • Concept of remineralization is part of ideology of the formulation invented.
  • Remineralizing system is a combination of ingredients saturating enamel of healthy teeth with minerals and initial cariogenic damage centres.
  • the formulation contains anticaries mineral additive.
  • anticaries mineral adjunct content is 0.2-3.3% by weight.
  • calcium glycerophosphate and magnesium inorganic and organic salt are preferable to use as anticaries mineral adjuncts.
  • inorganic or organic magnesium salts there may be used salts incorporating magnesium chloride, magnesium sulfate, magnesium nitrate, magnesium citrate, magnesium lactate, magnesium glycerophosphate, magnesium acetate, magnesium ascorbyl phosphate.
  • This adjunct is conditioned by teeth need for these elements in cases of caries and non-carious affections.
  • Calcium and phosphor are basic building elements of teeth enamel and take part in metabolic processes through the whole human life.
  • Non-carious teeth affections are often connected with calcium metabolic imbalance and are caused by adverse influence of endogeneous character like thyroid, pancreal, germ glands abnormalities, gastrointestinal tract diseases etc.; by unfavourable external influence such as ionizing radiation, daily long (more that 6 hours) computer work; by hazard influence such as acid fumes, metal dust and their combinations; a range of negative ecological effects, which result in substantial reduction of mineral components in dental tissues and then in affection in the form of caries, erosion defects.
  • Calcium glycerophosphate is a source of active phosphorus and calcium supply to teeth and periodontium tissues and facilitates process of mineralization, improves anticaries effect of formulation, intensifies anabolic processes in tissues.
  • Magnesium (of inorganic or organic salts) is a structural component of teeth. Magnesium is incorporated in complex formulation as microelement, which is a cofactor for phosphatases ensuring incorporation of phosphates into hard teeth tissues. Under the influence of phosphates there takes place hydrolysis of glycerophosphate and its bioavailability increases correspondingly. Since the risk of teeth demineralization is substantially lower in absence of solid dental deposit it is probable that formulation does not involve fluorides.
  • Fluoride content in mouth care formulation is relevant if soft dental deposit produces organic acids during breakdown of easy-fermented carbohydrates.
  • local fluoride action cannot be traced on teeth enamel maturation (for people aging over 20) even under this condition. It is shown in loss of its efficiency in caries prophylaxis.
  • sodium monofluorphosphate potassium monofluorphosphate, calcium monofluorphosphate or magnesium monofluorphosphate in amount of 0.6-1.8 wt %.
  • abrasive - 10-38 abrasive - 10-38
  • humectant - 11-50 gelling agent - 0.5-7
  • surfactant - 0.5-3 at least one surfactant - 0.5-2
  • humectant of a tooth paste there can be used one or several agents selected out of the group including sorbitol, glycerine, polyethylene glycol, propylene glycol.
  • gelling agent of a tooth paste there can be used one or several agents selected out of the group including hydroxyethyl cellulose,xanthan gum, guar gum, carbossimethyl callulose, potassium alginate, sodium alginate, thickening silica.
  • surfactants as sodium lauryl sulfate, alkylamidobetaine, polysorbate-20, sodium lauryl sarcosinate.
  • ether oils of peppermint oil, spearmint oil, clove, skinleaf and ginger oils as well as menthol, carvone, anethol, eucalyptol, methyl salicylate
  • sweeteners such as sodium saccharinate, potassium aspartame, potassium acesulfame, stevioside, xylitol, potassium and sodium glycyrrhizate.
  • preservative there can be used one or several substances selected out of the group including methylparaben, propylparaben, and their sodium salts, phenoxyethanol, benzoic acid, sodium benzoate, potassium sorbate.
  • Tooth pastes are prepared in the following way. Weigh required glycerine quantity, then add xanthan gum. Mix till formation of homogeneous mass. Weigh required quantity of water in a measuring bin, feed it into a mixer, with further adding of stevioside, sodium benzoate, sorbitol, kelp salt, sodium monofluorphosphate (as shown in examples 4,5), magnesium chloride (as shown in examples 1,2,3). Mix to formation of transparent solution. Xanthan gum suspension in glycerine is charged into the solution obtained, and mixing continues to formation of homogeneous mass. Vacuumize the formulation and mix for 10 minutes to full deaeration of the mixture.
  • the gel prepared is placed into polymer containers for filling.
  • Mouth rinses are prepared in the following way: Weigh water required, heat it up to 80 0 C, add glycerine, sorbitol (as in examples 3,4,5), xylitol, benzoic acid, magnesium glycerophosphate (examples 1,2), magnesium sulfate (examples 2,3,4,5), calcium glycerophosphate, magnesium monofluorphosphate (examples 1,2,3) and kelp salt. Mix to formation of transparent solution and cool down to the temperature of 40 0 C. In the process of mixing add dry liquorice root extract into the solution.
  • the mouth rinse prepared is placed into polymer containers. Efficacy evaluation
  • tooth paste according to example 3 from Table 1 has shown 69.5% reduction.
  • "Parodontax" application has shown 68.3% reduction.
  • gingivitis index in formulation prepared in accordance with the invention has shown more clear-cut reduction.
  • the invention can be prepared in the form of tooth paste as well as in the form of gel or liquid (mouth rinse, mouthwash) which are also under legal protection which covers all cases of realization of medicine for dental diseases prophylaxis.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

Technical result of the invention is achieved by practical use of effective formulation containing accessible components based on biologically active agents of natural origin, which has a comprehensive effect on dental tissues and can be recommended for periodontium prophylaxis and treatment as well as caries and non-carious affections prophylaxis. The main purpose of this invention was to elaborate high-efficiency formulation for prophylaxis of dental diseases of teeth and soft tissues of oral cavity in which synergist medications could heighten effect of each other attaining high therapeutic effect and results mentioned above. Medicine for dental diseases prophylaxis contains orally acceptable active and inert components. As active components there are used about 0.3% to 2.2% by weight of lipid concentrate of kelp, 0.5 % to 5.0 % by weight of kelp salt, 0.5% to 4.0 % by weight of dry extract of liquorice root, 0.01% to 0.25% by weight of one or more essential oils to enhance organoleptic properties, and 0.1% to 3.5 % by weight of anticaries mineral adjunct.

Description

Medicine for dental diseases prophylaxis Field of application
The invention relates to therapeutic and prophylactic formulations for oral care utilized in stomatology, particularly to medicine for dental diseases prophylaxis wherein biologically active agents of natural origin are used.
Background of invention
There is known medicine to prevent and treat oral diseases, including gingivitis, in the form of mouth rinse, tooth paste containing extract of Rosmarimus and anticeptic triclosan in order to enhance antibacterial effect (US 2006/0134025 Al, IPC A6 IK 8/97 (2006.01), 2006).
There is known therapeutic tooth paste containing plantain extract oil and pine leaf extract oil as well as mexidol and calcium citrate (RU 2310436 C2, IPC A61K 8/97 (2006.01), 2006). This formulation is used to prevent and treat caries, gingivitis, periodontal disease, stomatitis and is aimed to inhibit dental tartar build-up or to reduce dental tartar already built up.
The closest analogue out of the known formulations is tooth paste sold under "Parodontax" brand. It consists of baking soda and a blend of natural ingredients, flavor, sodium fluoride. As natural ingredients it contains a blend of alcohol extracts and oils of echinacea, myrrh, chamomile, rhatany, sage (US 2002/0031481 Al, IPC 7 A61K 7/16, 2002).
The known formulation has considerable concentration of baking soda as abrasive, more than 40% by weight that creates hypertonic medium and may result in gingival sponginess and recession. Therefore this tooth paste cannot be viewed as a means for permanent everyday dental and gingival prophylactic care. Moreover the known formulation does not provide necessary hard teeth tissues mineralization.
Substance of invention
Technical result of the invention is achieved by practical use of effective formulation containing accessible components based on biologically active agents of natural origin, which has a comprehensive effect on dental tissues and can be recommended for periodontium prophylaxis and treatment as well as caries and non-carious affections prophylaxis. The main purpose of this invention was to elaborate high-efficiency formulation for prophylaxis of dental diseases of teeth and soft tissues of oral cavity in which synergist medications could heighten effect of each other attaining high therapeutic effect and results mentioned above. Technical result is enhanced by medicine for dental diseases prophylaxis containing orally acceptable active and inert components.
Active components: about 0.3% to 2.2% by weight of lipid concentrate of kelp, 0.5% to 5.0 % by weight of kelp salt, 0.5% to 4.0 % by weight of dry extract of liquorice root, 0.01% to 0.25 % by weight of one or more essential oils to enhance organoleptic properties, and 0.1% to 3.5 % by weight of anticaries mineral adjunct. Inert components content is up to 100% by weight.
In a preferred embodiment, the medicine contains about 0.5% to 1.8% by weight of lipid concentrate of kelp, 0.8% to 4.2 % by weight of kelp salt, 0.8% to 3.6 % by weight of dry extract of liquorice root, 0.03% to 0.22 % by weight of one or more essential oils.
It is preferable when essential oils are used to improve organoleptic properties, hereinafter there are listed essential oils chosen out of the group including anise, thyme, lemon, mandarin, grapefruit, orange, bergamot, nerol, sage, tea tree, manuka, eucalyptus, fir, pine, juniper. Literal sources indicate to great value of biologically active agents contained in various species of kelp. There is shown particular perspective to extract lipid fractions out of laminaria of northern and far eastern seas. (Study and use of therapeutic and prophylactic medicine based on natural biologically active agents / edited by V.G. Bespalov and V.B. Nekrasova. - Spb.: Eskulap, 2000. - pp.175-176).
Lipid fractions are extracted in the following way regardless of seaweed species specificity: biologically active agents are ethanol extracted or highly volatile diluent extracted out of dry seaweed, then lipid concentrate and aqueous extract are skimmed. Essential biologically active components of lipid concentrate: chlorophyll derivatives, carotinoids (beta-carotine), mannitol, polysaccharides, fatty acids, including essential acids (polyunsaturated acids Cl 8 and C20 omega-3 and omega-6 are most prevalent fatty acids), organically associated phosphor and iodine, sulphur amino acids.
It is common knowledge that seaweed accumulates actively many elements and concentrates various macro-and microelements. While kelp processing there are derived inorganic salts. Biological properties of these compounds are determined by such elements as calcium, iodine, potassium, magnesium, manganese, molybdenium, copper, cobalt, ferrum, germanium, selenium, zink, etc.
As a whole natural biologically active agents obtained through complex kelp processing, included in the formulation for dental diseases prophylaxis intensify metabolic processes, improve trophism and blood circulation in periodontal tissues that reduces alveolar bones atrophy, contributes to nonspecific resistance increase.
Liquorice root extract has been used for thousands of years as a medicine. Medical opportunities are determined by chemical formulation. Liquorice root contains about 6% to 23% of triterpene saponoside glycyrrhizin, blended potassium-calcium-magnesium salt of glycyrrhizinic acid, derivatives of glycyrrhizinic acid, such as glabric acid, 18-glycyrrhetic, 18,19 - dihydroglycyrrhetic, 11-deoxyglycyrrhetic acids, liquiritic acid; up to 4% of flavonoids: liquiritin, isoliquiritin, licurazid, neoliquiritin, glabroside, uraloside, liquiritoside, glabrol, quercetin, kaempferol, apigenin,; mono- and disaccharides (up to 20%); starch (up to 34%); pectins (4-6%); resins(4%); phenolcarbonic acids and their derivatives (3-6%); salicylic, acetic, salicylic and ferulic acids; coumarins: herniarin, liqcoumarine, tanning agents (up to 14%); alkaloids; essential; organic acids such as tartaric, citric, malic, fumaric acids; steroids such as beta-sitosterol, estriol; macroelements such as potassium, calcium, magnesium, ferrum; microelements such as manganese, copper, zinc, barium, vanadium, selenium, nickel, strontium. To date out of liquorice there are derived and described 80 triterpenoids, over 300 individual phenolic compounds, dozens of polysaccharides, amino acids and the like. (Phytotherapy with elements of clinical pharmacology/ Edited by V.G.Koukes. M.:Meditcina, 1999. - pp.66-67). Flavonoids glabridin and glabren, licochalcon, licoricidin, isolicoflavon B showed antimicrobial activity in vitro in respect to Helicobacter pylori. These flavonoids are also active in relation to clarithromycins and amoxycillins resistant strains of Helicobacter pylori (Fukai T., Marumo A., Kaitou K., et al. Anti- Helicobacter pylori flavonoids from licorice extract. Life Sci. 2002 Aug 9;71(12):1449-63.).
A number of flavonoids derived from liquorice (glabridin, licochalcon) demonstrated antimicrobial activity against methycillin resistant strains of Staphylococcus aureus with minimum inhibitory concentrations of 3.13 to 12.5 μg/ml. Flavonois glabren, isolicoflavon, isolicoflavonol showed activity in relation to these strains in concentration of 1.56 to 25.0 μg/1. (Fukai T., Marumo
A., Kaitou K., et al. Antimicrobial activity of licorice flavonoids against methicillin-resistant Staphylococcus aureus. Fitoterapia. - 2002 Oct;73(6):536-9).
Dissolution in vitro test for powder enamel in acid acetate buffer and saliva where glucose was added, has shown that adding of 0.1 M of ammonium glycyrrhisate (out of liquorice extract) results in 30% dissolution decrease whereas under 18-hour incubation solubility reduces by 60% compared with solutions without ammonium glycyrrhisate. This effect can be explained by glycyrrhizic acid ability to inhibit glycolysis and demonstrate buffer properties, i.e. glycyrrhizic acid is presumably endowed with potential caries static properties. (W.M. Edgar Reduction in Enamel Dissolution by Liquorice and Glycyrrhizinic Acid. J.Dent Res 57(1): 59-64 January 1978).
Liquorice root extract is used not only in the form of medicine but also for preparing halva and licorice sweets in food industry which makes it attractive as a means for oral hygiene.
Role of microelements present in liquorice root extract as well as in kelp salt, is relevant. Physiological effect and microelement participation in biochemical metabolic reactions in teeth tissues are discovered to a certain extent on the basis of the data concerning metabolism principles in hard teeth tissues mineralization including teeth and bone. Mineralization is influenced by biological activators. One of these activators is phosphatases which abound in dental germs. It is possible that microelements effect is shown through phosphatases activation. Definite microelements are supposed to take part in mineralization nucleolus formation resulting from collagen attachment and formation of metalloprotein active complexes. Microelements may have immediate influence on mature teeth by compounding to nonspecific protein contained in dental lymph, that leads to formation of biologically active agents
(N.A.Kodola Microelements in dental caries prophylaxis. Kiev, "Zdorovie", 1979, pp.22-23).
Lipid concentrate of kelp has offending scent that is negatively commented by some consumers. In this respect, it has been proposed to introduce one or several ether oils into tooth pastes formulation in order to mask offending scent.
There have been chosen following ether oils: anise, thyme, lemon, mandarin, grapefruit, bergamot, nerol, sage, tea tree, manuka, eucalyptus, fir, pine, juniper.
Liquorice extract also has a positive effect on tooth paste flavor. Ether oils coupled with liquorice extract perform a number of antimicrobial functions. Concept of remineralization is part of ideology of the formulation invented. Remineralizing system is a combination of ingredients saturating enamel of healthy teeth with minerals and initial cariogenic damage centres.
For attaining remineralizing effect the formulation contains anticaries mineral additive. In a preferred embodiment, anticaries mineral adjunct content is 0.2-3.3% by weight.
It is preferable to use calcium glycerophosphate and magnesium inorganic and organic salt as anticaries mineral adjuncts.
As inorganic or organic magnesium salts there may be used salts incorporating magnesium chloride, magnesium sulfate, magnesium nitrate, magnesium citrate, magnesium lactate, magnesium glycerophosphate, magnesium acetate, magnesium ascorbyl phosphate.
This adjunct is conditioned by teeth need for these elements in cases of caries and non-carious affections. Calcium and phosphor are basic building elements of teeth enamel and take part in metabolic processes through the whole human life. Non-carious teeth affections are often connected with calcium metabolic imbalance and are caused by adverse influence of endogeneous character like thyroid, pancreal, germ glands abnormalities, gastrointestinal tract diseases etc.; by unfavourable external influence such as ionizing radiation, daily long (more that 6 hours) computer work; by hazard influence such as acid fumes, metal dust and their combinations; a range of negative ecological effects, which result in substantial reduction of mineral components in dental tissues and then in affection in the form of caries, erosion defects.
Thereby local application of therapeutic and prophylactic formulations containing phosphor-calcium additives makes it possible not only to prevent but to a certain degree makes up for the loss in case of disease.
Calcium glycerophosphate is a source of active phosphorus and calcium supply to teeth and periodontium tissues and facilitates process of mineralization, improves anticaries effect of formulation, intensifies anabolic processes in tissues. Magnesium (of inorganic or organic salts) is a structural component of teeth. Magnesium is incorporated in complex formulation as microelement, which is a cofactor for phosphatases ensuring incorporation of phosphates into hard teeth tissues. Under the influence of phosphates there takes place hydrolysis of glycerophosphate and its bioavailability increases correspondingly. Since the risk of teeth demineralization is substantially lower in absence of solid dental deposit it is probable that formulation does not involve fluorides. Fluoride content in mouth care formulation is relevant if soft dental deposit produces organic acids during breakdown of easy-fermented carbohydrates. However, local fluoride action cannot be traced on teeth enamel maturation (for people aging over 20) even under this condition. It is shown in loss of its efficiency in caries prophylaxis.
At the same time it is admitted in proposed formulation that as anticaries mineral additive there are used sodium monofluorphosphate, potassium monofluorphosphate, calcium monofluorphosphate or magnesium monofluorphosphate in amount of 0.6-1.8 wt %.
It is preferable to prepare medicine for dental disease prophylaxis in the form of tooth paste. In this case it involves several inert components, wt.%: abrasive - 10-38, humectant - 11-50, gelling agent - 0.5-7, at least one surfactant - 0.5-3, at least one flavor - 0.5-2, at least one preservative - 0.01-0.5.
While preparing a paste, as abrasive, there can be used one or several substances selected out of the group including dicalcium phosphate dihydrate, anhydrious dicalcium phosphate, calcium carbonate, silica, aluminium oxide, aluminium hydroxide, polymethacrylate.
As humectant of a tooth paste there can be used one or several agents selected out of the group including sorbitol, glycerine, polyethylene glycol, propylene glycol. As gelling agent of a tooth paste there can be used one or several agents selected out of the group including hydroxyethyl cellulose,xanthan gum, guar gum, carbossimethyl callulose, potassium alginate, sodium alginate, thickening silica.
In the process of preparing medicine for dental diseases prophylaxis, there may be used such surfactants as sodium lauryl sulfate, alkylamidobetaine, polysorbate-20, sodium lauryl sarcosinate.
As flavor there may be used one or several substances of the following group comprising ether oils of peppermint oil, spearmint oil, clove, skinleaf and ginger oils, as well as menthol, carvone, anethol, eucalyptol, methyl salicylate; sweeteners such as sodium saccharinate, potassium aspartame, potassium acesulfame, stevioside, xylitol, potassium and sodium glycyrrhizate.
As preservative there can be used one or several substances selected out of the group including methylparaben, propylparaben, and their sodium salts, phenoxyethanol, benzoic acid, sodium benzoate, potassium sorbate. Realization of invention
Medicine for dental diseases prophylaxis has been described above with reference to illustrative examples.
Qualitative and quantitave tooth paste formulation is represented in Table 1.
Table 1
Tooth pastes are prepared in the following way. Weigh required glycerine quantity, then add xanthan gum. Mix till formation of homogeneous mass. Weigh required quantity of water in a measuring bin, feed it into a mixer, with further adding of stevioside, sodium benzoate, sorbitol, kelp salt, sodium monofluorphosphate (as shown in examples 4,5), magnesium chloride (as shown in examples 1,2,3). Mix to formation of transparent solution. Xanthan gum suspension in glycerine is charged into the solution obtained, and mixing continues to formation of homogeneous mass. Vacuumize the formulation and mix for 10 minutes to full deaeration of the mixture.
Then add calcium glycerophosphate or magnesium glycerophosphate (as demonstrated in examples 4,5), mixing continues for 15-20 minutes. Then add thickening silica (as shown in examples 1,2,3,4), calcium carbonate (as shown in examples 1,2,4,5), dicalcium phosphate dihydrate (as in examples 1,2,3), mixing under vacuum continues for 40-50 minutes.
Homogenize tooth-paste with homogenizing pump for 10-20 minutes. Charge the mixer with flavor, ether oil or ether oils blend (as in examples 3,4) and lipid concentrate of kelp. Mix to formation of homogeneous mass for 20-30 minutes.
Feed dry liquorice root extract, sodium lauryl sulfate (as shown in examples 1,2,3), alkylamidobetaine (as in examples 2,3,4,5) and mix for 20-30 minutes till formation of homogeneous mass. The tooth paste prepared is placed into polymer container for filling.
Qualitative and quantitave gel formulation is illustrated in Table 2.
Gels are prepared in the following way.
Weigh required quantity of propylene glycol, add hydroxyethyl cellulose. Mix to formation of homogeneous mass. Weigh required quality of water in a measuring bin, feed the water into a mixer, add potassium glycyrrhizate, sodium methylparaben, kelp salt, potassium monofluorphosphate (as in examples 4,5), magnesium lactate. Mix to formation of transparent solution.
Charge hydroxyethyl cellulose suspension in glycerine into the solution obtained and mix till formation of homogeneous mass. Mix the formulation under vacuum for 10 minutes to deaeration of the mixture.
Add calcium glycerophosphate with further mixing for 15-20 minutes. Then add thickening silica (as in examples 1,2,3), mix for 40-50 minutes under vacuum.
Table 2
Then homogenize gel with homogenizing pump for 10-20 minutes. Charge flavor, ether oil or blend of ether oils (as in examples 2,3,4) as well as lipid concentrate of kelp into the mixer. Mix to formation of homogeneous mass for 20- 30 minutes.
Feed dry liquorice root extract, sodium lauryl sarcosinate and mix to formation of homogeneous mass for 20-30 minutes. The gel prepared is placed into polymer containers for filling.
Qualitative and quantitave formulation of mouth rinses are shown in Table 3.
Mouth rinses are prepared in the following way: Weigh water required, heat it up to 80 0C, add glycerine, sorbitol (as in examples 3,4,5), xylitol, benzoic acid, magnesium glycerophosphate (examples 1,2), magnesium sulfate (examples 2,3,4,5), calcium glycerophosphate, magnesium monofluorphosphate (examples 1,2,3) and kelp salt. Mix to formation of transparent solution and cool down to the temperature of 40 0C. In the process of mixing add dry liquorice root extract into the solution.
Table 3
In a separate container prepare solution of ether oils, flavor and lipid concentrate of kelp in polysorbate-20. Heat the obtained solution up to 40 0C while mixing.
In the process of mixing add the ingredients solution in polysorbate-20 to the water solution. Mix for 20-30 minutes under the temperature of 40 0C, then cool down to the temperature of 20-25 0C and filter.
The mouth rinse prepared is placed into polymer containers. Efficacy evaluation
Efficacy of medicine for dental diseases prophylaxis has been tested on a group of volunteers in order to evaluate anti-inflammatory action. There has been used medicine in the form of tooth paste prepared in correspondence with Example 3 of Table 1. As a comparison there was used "Parodontax" tooth paste prepared in accordance with the analogue mentioned above.
Two groups of 15 and 16 people have taken part in clinical studies. There were chosen volunteers with the age varying from 15 to 45 diagnosed with chronic catarrhal gingivitis and chronic periodontitis of mild severity. The experiment took 14 days. Anti-inflammatory effect was evaluated by PMA index (C.Parma, 1964) Index evaluation has been made before and after investigation, i.e. in 14 days.
Clinical data are demonstrated in Table 4.
Table 4
Thus application of tooth paste according to example 3 from Table 1 has shown 69.5% reduction. "Parodontax" application has shown 68.3% reduction. In other words gingivitis index in formulation prepared in accordance with the invention has shown more clear-cut reduction.
Thereby it has been elaborated high-efficiency and available therapeutic and prophylactic medicine which has considerable influence on oral cavity tissues.
This medicine can be recommended for treatment and prophylaxis of periodontium diseases as well as for caries and non-carious affections prophylaxis. The invention can be prepared in the form of tooth paste as well as in the form of gel or liquid (mouth rinse, mouthwash) which are also under legal protection which covers all cases of realization of medicine for dental diseases prophylaxis.

Claims

Claims
1. Medicine for dental diseases prophylaxis containing orally acceptable active and inert components characterized by comprising about 0.3% to 2.2% by weight of lipid concentrate of kelp, 0.5% to 5.0 % by weight of kelp salt, 0.5% to 4.0% by weight of dry liquorice root extract, 0.01% to 0.25% by weight of one or more essential oils to improve organoleptic properties and 0.1% to 3.5% by weight of anti-caries mineral adjunct, up to 100% by weight of inert components.
2. Medicine according to claim 1, comprising about 0.5% to 1.8% by weight of lipid concentrate of kelp.
3. Medicine according to claim 1, comprising about 0.8% to 4.2% by weight of kelp salt.
4. Medicine according to claim 1, comprising about 0.8% to 3.6% by weight of dry liquorice root extract.
5. Medicine according to claim 1, comprising about 0.03% to 0.22% by weight of one or more essential oils.
6. Medicine according to claim 1, comprising essential oils selected out of the group containing anise, thyme, lemon, mandarin, grapefruit, orange, bergamot, nerol, sage, tea tree, manuka, eucalyptus, fir, pine, juniper.
7. Medicine according to claim 1, comprising about 0.2% to 3.3% by weight of anticaries mineral adjuncts.
8. Medicine according to claim 1, comprising calcium glycerophosphate and inorganic or organic salt as anti-caries mineral adjuncts.
9. Medicine according to claim 8, comprising salts selected out of the group of magnesium chloride, magnesium sulfate, magnesium nitrate, magnesium citrate, magnesium lactate, magnesium glycerophosphate, magnesium acetate, magnesium ascorbyl phosphate as inorganic and organic magnesium salts.
10. Medicine according to claim 8, comprising anticaries mineral adjunct that contains optionally one or several agents selected out of the group of sodium monofluorphosphate, potassium monofluorphosphate, calcium monofluorphosphate, 0.6% to 1.8% by weight of magnesium monofluorphosphate.
11. Medicine according to claim 1 comprising, in the form of tooth paste, the following inert components, wt. %; abrasive - 10-38, humectant - 11-50, gelling agent- 0.5-7, at least one surfactant - 0.5-3, at least one flavor - 0.5-2, at least one preservative - 0.01-0.5.
12. Medicine according to claim 11, wherein the abrasive is selected out of the group containing dicalcium phosphate dihydrate, anhydrious dicalcium phosphate, calcium carbonate , silica, aluminium oxide, aluminium hydroxide, polymethacrylate .
13. Medicine according to claim 11, wherein the humectant is selected out of the group containing sorbitol, glycerine, polyethylene glycol, propylene glycol.
14. Medicine according to claim 11, wherein the gelling agent is selected out of the group containing hydroxyethyl cellulose, xanthan gum, guar gum, carboxymethyl cellulose, potassium alginate, sodium alginate, thickening silica.
15. Medicine according to claim 11, wherein the surfactant is selected out of the group containing sodium lauryl sulfate, alkylamidobetaine, polysorbate-20, sodium lauryl sarcosinate.
16. Medicine according to claim 11, wherein the flavor is selected out of the group containing ether oils of peppermint, spearmint, clove, skinleaf and ginger, as well as menthol, carvone, anethol, eucalyptol, methyl salicylate, sweeteners like sodium saccharinate, potassium aspartame, potassium acesulfame, stevioside, xylitol, potassium and sodium glycyrrhisate.
17. Medicine according to claim 11, wherein the preservative is selected out of the group containing methylparaben, propylparaben, and their sodium salts, phenoxyethanol, benzoic acid, sodium benzoate, potassium sorbate.
EP10775155A 2009-05-15 2010-03-23 Medicine for dental diseases prophylaxis Withdrawn EP2429558A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EA200900764A EA200900764A1 (en) 2009-05-15 2009-05-15 COMPOSITION FOR PREVENTION OF DENTAL DISEASES
PCT/RU2010/000130 WO2010131994A1 (en) 2009-05-15 2010-03-23 Medicine for dental diseases prophylaxis

Publications (2)

Publication Number Publication Date
EP2429558A1 true EP2429558A1 (en) 2012-03-21
EP2429558A4 EP2429558A4 (en) 2012-12-05

Family

ID=42307745

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10775155A Withdrawn EP2429558A4 (en) 2009-05-15 2010-03-23 Medicine for dental diseases prophylaxis

Country Status (4)

Country Link
EP (1) EP2429558A4 (en)
EA (1) EA200900764A1 (en)
UA (1) UA75461U (en)
WO (1) WO2010131994A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA120497C2 (en) 2013-06-18 2019-12-26 Елджи Хаусхолд Енд Хелт Кер Лтд. Oral composition
GB2544782B (en) * 2015-11-26 2020-07-15 Fontus Health Ltd Solution
EP3724201B1 (en) * 2017-12-15 2022-02-02 Colgate-Palmolive Company Novel compounds
RU2691410C1 (en) * 2018-04-26 2019-06-13 Федеральное государственное бюджетное учреждение науки "Институт морских биологических исследований имени А.О. Ковалевского РАН" Oral and throat care means
LV15495A (en) * 2018-11-09 2020-05-20 Gerčikovs Iļja Preparation for oral cavity care
RU2699560C1 (en) * 2019-04-09 2019-09-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Астраханский ГМУ Минздрава России) Dental gel with a phytopeloid composition
RU2706010C1 (en) * 2019-04-17 2019-11-13 Общество с ограниченной ответственностью "АЛЬФА-ДЕНТ" Dental gel

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE693094A (en) * 1966-02-14 1967-07-03
RU1782600C (en) * 1984-09-12 1992-12-23 Одесский научно-исследовательский институт стоматологии Antihypoxic drug for treating parodontitis
RU2006223C1 (en) * 1992-12-28 1994-01-30 Научно-производственная и внедренческая фирма "Юнитекс" Composition for oral cavity diseases prophylaxis
JPH0948715A (en) * 1995-08-04 1997-02-18 Lion Corp Composition for oral cavity
US20020031481A1 (en) * 1998-02-27 2002-03-14 Jin Xu Stable herbal dentrifice
RU2160585C1 (en) * 1999-11-17 2000-12-20 Зао "Оргполимерсинтез" Composition for preventing oral cavity diseases
RU2204990C1 (en) * 2002-03-14 2003-05-27 ООО НПО "Фитофарм" Dental disease and parodontium prophylaxis composition
US6485711B1 (en) * 2002-03-21 2002-11-26 Michael J. Olmstead Organic toothpaste containing saponin
CN1772049A (en) * 2004-11-11 2006-05-17 刘国林 Medicine or health food composition for protecting teeth
US20060134025A1 (en) * 2004-12-17 2006-06-22 Colgate-Palmolive Company Oral compositions containing extracts of Rosmarinus and related methods
JP5684454B2 (en) * 2005-11-25 2015-03-11 “ダブリューディーエス” カンパニー Oral care therapeutic and prophylactic compositions
RU2309763C2 (en) * 2005-12-06 2007-11-10 ГУ Дальневосточный научный центр физиологии и патологии дыхания Сибирского отделения Российской академии медицинских наук Agent with lipid-correcting and antioxidant properties
US8236360B2 (en) * 2007-05-02 2012-08-07 Tom's Of Maine, Inc. Supercritical CO2 liquorice extract and products made there from
EA200701932A1 (en) * 2007-08-29 2009-02-27 Общество С Ограниченной Ответственностью "Вдс" TABLET FOR PREVENTION AND TREATMENT OF TEETH DISEASES AND PERIODONTAL

Non-Patent Citations (19)

* Cited by examiner, † Cited by third party
Title
ABU ALI SINA: "Al-Qaanoon-fil-Tibb", vol. V, 1996, pages: 194
ABU MOHAMMAD ZAKARIYYA RAZI: "Kitaab-al-Haawi-fil-Tibb", vol. III, 1977, pages: 196 - 197
ALI IBN-E-ABBAAS MAJOOSI: "Kaamil al Sena'ah", vol. II, 2005, pages: 305 - 306
ALI IBN-E-ABBAAS MAJOOSIE: "Kaamil-al-Sena'ah", vol. II, 2005, pages: 305 - 306
BHAVAMISRA: "Bhavaprakasa", vol. I, 1999, pages: 110
CAKRADATTAH: "Cakradattah", vol. 4, 2002, pages: 436
CAKRAPANIDATTAH: "Cakradattah", vol. 4, 2002, pages: 329
DATABASE TKDL [online] "Dantakurcika", XP003032319, Database accession no. RS/3007A
DATABASE TKDL [online] "Dantpapputaka Pratisarana", XP003032326, Database accession no. RS23/1573
DATABASE TKDL [online] "Habb-e-Ward", XP003032321, Database accession no. AH3/2811
DATABASE TKDL [online] "Kusthadiyogah", XP003032320, Database accession no. HG/2382
DATABASE TKDL [online] "mustadi tailam", XP003032327, Database accession no. RG1/1773
DATABASE TKDL [online] "Sannon Anisoon", XP003032324, Database accession no. MH3/245M
DATABASE TKDL [online] "Sanoon Muqawwi-e-Asnan Wa Lesah", XP003032323, Database accession no. AH3/2808
DATABASE TKDL [online] "Sanoon-e-Qinna", XP003032325, Database accession no. AA3/844
DATABASE TKDL [online] "Shaayaaf Bara-e-Asnaan", XP003032322, Database accession no. AH2/492
MOHAMMAD AZAM KHAN: "Muheet-e-Azam", vol. I, 1896, pages: 228
See also references of WO2010131994A1
VAGABHATA: "Astanga Hrdaya", vol. 8, 1998, pages: 853

Also Published As

Publication number Publication date
EP2429558A4 (en) 2012-12-05
EA013370B1 (en) 2010-04-30
WO2010131994A1 (en) 2010-11-18
UA75461U (en) 2012-12-10
EA200900764A1 (en) 2010-04-30

Similar Documents

Publication Publication Date Title
WO2010131994A1 (en) Medicine for dental diseases prophylaxis
EP1952801A1 (en) Oral cavity care curative and prophylactic composition
CN106691883A (en) Toothpaste and preparation method thereof
BR112017013730B1 (en) biphasic mouthwash, method for treating dry mouth, method for preparing a biphasic mouthwash and use of a hydrophilic phase and a hydrophobic phase
CN108245552B (en) Composition for oral cavity and application thereof
JP2014513723A (en) Oral care composition
CN108938501A (en) Chinese medicine composition and oral care product applied to oral care product
KR101733916B1 (en) Toothpaste comprising natural surface-active agent and the fabrication method the same
US20020031481A1 (en) Stable herbal dentrifice
JP2002503257A (en) Stable herbal toothpaste
AU2002256299A1 (en) Stable herbal dentifrice
Saikiran et al. Pulpotomy medicaments in primary teeth: A literature review of natural alternatives
RU2457829C2 (en) Mineral and vitamin complex for strengthening tooth enamel, composition for oral cavity hygiene and toothpaste
CN107007538B (en) Oral care composition containing marine elements, application of oral care composition and toothpaste containing marine elements
WO2005072691A1 (en) Composition for inhibiting halitosis
KR102547873B1 (en) Oral composition
US20040115138A1 (en) Stable herbal dentifrice
CN105287328A (en) Manuka honey toothpaste for pregnant women and preparation method of toothpaste
DE102017009626A1 (en) Oral composition with citrus extract and hydroxyapatite
JP2004231602A (en) Buccal composition containing galenical extract having antioxidation activity
CN113318057A (en) Old people nursing toothpaste and preparation method and application thereof
CN102499902B (en) Oral cavity care composition
RU2160585C1 (en) Composition for preventing oral cavity diseases
JP2001089346A (en) Composition for oral cavity
TWI817111B (en) Compositions for oral cleaning

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110607

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/484 20060101ALI20121024BHEP

Ipc: A61K 33/42 20060101ALI20121024BHEP

Ipc: A61K 33/14 20060101ALI20121024BHEP

Ipc: A61K 33/06 20060101ALI20121024BHEP

Ipc: A61Q 11/00 20060101ALI20121024BHEP

Ipc: A61P 1/02 20060101ALI20121024BHEP

Ipc: A61K 33/00 20060101ALI20121024BHEP

Ipc: A61K 8/97 20060101ALI20121024BHEP

Ipc: A61K 45/06 20060101ALI20121024BHEP

Ipc: A61K 36/03 20060101AFI20121024BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20121105

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

17Q First examination report despatched

Effective date: 20130722

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131203